Digital prescription platform Healthera has been backed by Cambridge Enterprise, its Seed Funds vehicle and UCEF.

UK-based digital prescription platform Healthera secured £3m ($3.8m) yesterday in a series A round backed by Cambridge Enterprise Seed Funds, part of the university’s Cambridge Enterprise tech transfer office.

Accelerated Digital Ventures led the round, which also featured University of Cambridge Enterprise Fund (UCEF), a co-investment vehicle managed on the university’s behalf by Parkwalk Advisors, and charity Future Care Capital.

Founded in 2015, Healthera has developed a digital platform that allows patients to order repeat medical prescriptions without the need to visit their general practitioner (GP). Patients connect to their local pharmacy through a mobile app, which also sends updates to the GP.

Healthera will use the funding to expand its product range and accelerate its commercialisation strategy as the company looks to treble in commercial stature to help corner the market.

The company was co-founded by three Cambridge alumni, including company chief executive Quintus Liu, who studied mechanical engineering, and managing director Martin Hao, who graduated with an MA in information and computer engineering.

Liu and Hao were assisted by Jin Dai, a former research assistant at Cambridge’s Centre for Smart Infrastructure and Construction who now acts as vice-president of product at Healthera.

Healthera had obtained an undisclosed seed sum in 2016 from University of Cambridge, UCEF III, FT Capital and unnamed angel investors. The company also secured an unspecified amount in pre-seed funding from unnamed backers the previous year.